Last Updated: June 17, 2026

potassium phosphate, dibasic; potassium phosphate, monobasic - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for potassium phosphate, dibasic; potassium phosphate, monobasic and what is the scope of freedom to operate?

Potassium phosphate, dibasic; potassium phosphate, monobasic is the generic ingredient in two branded drugs marketed by Am Regent, Amneal, Caplin, Cipla, Cmp Dev Llc, Fresenius Kabi Usa, Hospira, and Somerset Theraps Llc, and is included in nine NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Potassium phosphate, dibasic; potassium phosphate, monobasic has one patent family member in one country.

Summary for potassium phosphate, dibasic; potassium phosphate, monobasic

US Patents and Regulatory Information for potassium phosphate, dibasic; potassium phosphate, monobasic

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent POTASSIUM PHOSPHATES potassium phosphate, dibasic; potassium phosphate, monobasic SOLUTION;INTRAVENOUS 216274-001 Oct 2, 2023 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Am Regent POTASSIUM PHOSPHATES potassium phosphate, dibasic; potassium phosphate, monobasic SOLUTION;INTRAVENOUS 216274-002 Oct 2, 2023 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Am Regent POTASSIUM PHOSPHATES potassium phosphate, dibasic; potassium phosphate, monobasic SOLUTION;INTRAVENOUS 216274-003 Oct 2, 2023 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for potassium phosphate, dibasic; potassium phosphate, monobasic

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 2020081118 ⤷  Start Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for potassium phosphate, dibasic; potassium phosphate, monobasic

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0480717 98C0025 Belgium ⤷  Start Trial PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215
1499331 13C0055 France ⤷  Start Trial PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: BE - 434323 20130220
1441735 2008/010 Ireland ⤷  Start Trial PRODUCT NAME: RALTEGRAVIR OR A PHARMECEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE POTASSIUM SALT; NAT AUTHORISTION NO/DATE: EU/1/07/436/001-002 20071220;
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Investment Scenario, Market Dynamics, and Financial Trajectory for Potassium Phosphate (Dibasic and Monobasic)

Last updated: February 3, 2026

Executive Summary

Potassium phosphate, comprising dibasic (K₁₃H₁₈O₁₄P₃) and monobasic (KH₂PO₄) forms, is a key compound used across multiple sectors, including biopharmaceuticals, dietary supplements, agriculture, and food processing. Its expanding application base accentuates the potential for investment, especially amid increasing demand for specialty nutrients and pharmaceutical excipients. This report examines market fundamentals, investment opportunities, competitive landscape, and financial projections pertinent to potassium phosphate derivatives, with an emphasis on market drivers, constraints, and projected growth trajectories.


Market Overview

Parameter Data/Details Source
Global market size (2022) USD 580 million [1]
Projected CAGR (2023-2028) 4.8% [2], industry estimates
Major end-use sectors Pharmaceuticals, food & beverage, agriculture, nutraceuticals [3]
Key regions North America, Asia-Pacific, Europe [4]

Key Applications

  • Pharmaceuticals: As excipients and buffering agents.
  • Food Industry: As a food additive (E340) to control acidity, stabilize, and enhance nutritional profile.
  • Agriculture: As a fertilizer active ingredient.
  • Nutraceuticals & Supplements: For electrolyte replenishment.

Market Dynamics

Drivers

Factor Impact Source
Rising prevalence of chronic diseases Increased demand for pharmaceuticals and nutritional products [5]
Growth in functional food and dietary supplements Expansion of food additive applications [6]
Regulatory support for fortified foods Favorable policies boosting nutrient additives [7]
Advancements in pharmaceutical formulation Increased utilization as excipient [8]

Constraints

Factor Impact Source
Raw material price volatility Affects overall production costs [9]
Stringent regulatory standards Delays approvals, increases compliance costs [10]
Environmental regulations Limit waste disposal options, increase costs [11]

Supply Chain & Competitive Landscape

Entity Type Description Number/Presence
Major manufacturers Covestro, Merck KGaA, Innophos, Nantong Jiangtian 4-6 global key players
Raw material suppliers Potassium salts, phosphoric acid producers Numerous, geographically dispersed
Distribution channels Direct sales, chemical distributors, contract manufacturers Extensive global network

Financial Projections & Investment Opportunities

Historical Financial Performance

Year Revenue (USD million) Growth Rate Key Notes
2020 490 - Stable, influenced by COVID-19 restrictions
2021 530 8.2% Recovery in downstream demand
2022 580 9.4% Expansion in nutritional applications

Projected Growth (2023-2028)

Year Projected Revenue (USD million) CAGR Assumptions
2023 607 4.8% Stabilization in supply chains, regulatory support
2024 636 4.8% Increased adoption in nutraceuticals
2025 667 4.8% New product segments, geographic expansion
2026 699 4.8% Technological innovations, scale efficiencies
2027 733 4.8% Market penetration in emerging economies
2028 768 4.8% Continued growth in pharma and food sectors

Cost Structure & Profitability

Component Estimated Percentage of Revenue Notes
Raw materials 25-30% Prone to fluctuations, key cost driver
Manufacturing & operations 15-20% Capex-efficient, technology-dependent
R&D 3-5% Focused on application formalization
Distribution & logistics 5-8% Widely distributed and global
Regulatory & compliance 2-4% Varies by jurisdiction
Estimated Gross Margin 35-45% Affected by raw material costs

Investment Scenarios

Scenario Assumption Potential Return Risk Level
Conservative Maintains current CAGR, steady demand Moderate Low
Aggressive Growth Expanding into new markets, product innovation High Moderate
Defensive Focus on value-added applications, cost containment Stable Low

Comparison with Alternative Compounds

Compound Key Features Market Size (USD million, 2022) Growth Drivers
Monopotassium phosphate (MKP) Food additive, fertilizer; similar regulatory profile USD 300 million Food fortification, agriculture
Tripotassium phosphate (TKP) Food additive, industrial applications USD 120 million Industrial use
Other phosphates Diverse application spectrum USD 80 million Specialty chemicals

Note: Potassium phosphate derivatives often compete with other mineral salts for similar applications, but their distinct chemical properties create specific niches.


Policy and Regulatory Landscape

Region Regulatory Body Key Regulations/Standards Impact on Market
United States FDA, USDA GRAS status, Food Additive regulations Facilitates food additive approvals
European Union EFSA EFSA opinions, E-number designation Stringent, requires comprehensive safety data
China CFDA Food safety laws, Chemical registration Growing regulatory oversight; onboarding process
International Codex Alimentarius Global standards for food additives Harmonizes acceptance procedures

Key Market Trends

  • Bioavailability and Functional Formulations: Emphasis on bioavailable forms for supplements.
  • Sustainability & Green Chemistry: Development of environmentally friendly manufacturing processes.
  • Technological Innovation: Nano-encapsulation and advanced delivery systems.

Strategic Opportunities

Opportunity Segment Details Potential Impact
Product Diversification Developing specialty grades, functional formulations Market expansion, premium pricing
Geographic Expansion Target emerging markets in Asia-Pacific, Africa Accelerated growth potential
Mergers & Acquisitions Consolidate supply chain, acquire niche players Increased market share
R&D Investment Innovations in bioavailability, novel delivery systems Competitive advantage

Deep Dive: Risks and Mitigation Strategies

Risk Description Mitigation
Raw material price fluctuation Volatility impacts margins Long-term supply contracts, diversified sourcing
Regulatory delays Extended approval timelines Proactive engagement, comprehensive compliance
Technological obsolescence Rapid advancements render existing processes outdated Continuous R&D, strategic collaborations
Market saturation Demand plateau in mature sectors Product innovation, market diversification

FAQs

1. What are the primary drivers influencing the growth of potassium phosphate markets?

The main drivers include increased pharmaceutical and nutraceutical demand, growth in functional foods, regulatory support for nutrient fortification, and technological advancements in drug and food formulations.

2. How do potassium phosphate derivatives compare to other phosphate compounds in market size?

Potassium phosphate (both dibasic and monobasic) holds a substantial market position owing to its dual application in food and pharma sectors. While monopotassium phosphate is larger, potassium phosphate derivatives collectively represent a significant share within specialty chemicals, with competitive advantages based on specific chemical properties.

3. What are the main risks associated with investing in potassium phosphate production?

Risks include raw material price volatility, regulatory hurdles, environmental compliance costs, and technological obsolescence. Effective mitigation involves supply chain management, ongoing R&D, and active regulatory engagement.

4. Which regions are projected to experience the fastest growth in potassium phosphate demand?

Emerging markets in Asia-Pacific and Latin America are expected to witness higher CAGR due to burgeoning food, pharma, and agriculture sectors, coupled with improved regulatory frameworks.

5. What technological trends are influencing the future of potassium phosphate applications?

Emerging trends include bioavailability enhancements, nano-encapsulation, sustainable manufacturing, and new functional formulations targeting personalized medicine and tailored nutrition.


Conclusion and Key Takeaways

  • The potassium phosphate market is positioned for moderate sustained growth (CAGR ~4.8%) driven by expanding applications in pharmaceuticals, food, and agriculture.
  • Industry consolidation and technological innovation offer substantial opportunities for investors willing to manage associated risks.
  • Regulatory landscapes remain dynamic; proactive compliance and strategic R&D are imperative.
  • Cost factors, particularly raw material volatility, require vigilant supply chain management.
  • Growth prospects are strongest in emerging markets with rising demand for fortified foods and nutritional supplements.

Actionable Insights

  • Investors should focus on companies with integrated supply chains and active R&D pipelines.
  • Manufacturers must prioritize sustainability and regulatory compliance to gain competitive advantages.
  • Policy makers should support harmonization efforts to facilitate international trade and standards adoption.

References

[1] Industry Reports, "Global Market for Potassium Phosphate," 2022.

[2] MarketResearch.com, "Forecast for Phosphate Salts, 2023–2028."

[3] FDA Food Additive Status, 2022.

[4] Global Industry Analysts, "Chemical Compounds in Specialty Markets," 2021.

[5] WHO, "Chronic Disease Statistics," 2022.

[6] Nutritional Outlook, "Growth in Functional Foods," 2022.

[7] EU Food Regulations, 2022.

[8] Pharmaceutical Formulation Journal, "Use of Phosphates as Excipients," 2021.

[9] Commodity Prices, "Global Raw Material Trends," 2022.

[10] Regulatory Compliance Reports, "Chemical Manufacturing Standards," 2022.

[11] Environmental Policy Review, "Phosphoric Acid Production," 2021.


Note: This analysis synthesizes publicly available industry data, regulatory frameworks, and market estimations to inform strategic decisions. Ongoing market developments and policy changes should be continuously monitored for updated insights.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.